National Bank of Canada’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
National Bank of Canada's REGN Position: Q1 2026 in Review
National Bank of Canada increased its Regeneron Pharmaceuticals (REGN) stake by 8.5% in Q1 2026, buying an estimated $7.8M and bringing the position to 130,006 shares worth $100M. The position accounts for 0.09% of the portfolio, ranked #184.
National Bank of Canada first reported a position in REGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $105M in Q4 2023. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- National Bank of Canada held 130,006 shares of Regeneron Pharmaceuticals worth $100M as of Q1 2026.
- National Bank of Canada bought 10,194 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $7.8M.
- Regeneron Pharmaceuticals made up 0.09% of National Bank of Canada's portfolio in Q1 2026, its #184 holding.
- National Bank of Canada first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's Regeneron Pharmaceuticals position peaked at $105M in Q4 2023.
- 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.